BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen C, Fichna J, Laudon M, Storr M. Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain. World J Gastroenterol 2014; 20(5): 1298-1304 [PMID: 24574803 DOI: 10.3748/wjg.v20.i5.1298]
URL: https://www.wjgnet.com/1007-9327/full/v20/i5/1298.htm
Number Citing Articles
1
Natasha Ivanova, Zlatina Nenchovska, Milena Atanasova, Moshe Laudon, Rumyana Mitreva, Jana Tchekalarova. Chronic Piromelatine Treatment Alleviates Anxiety, Depressive Responses and Abnormal Hypothalamic–Pituitary–Adrenal Axis Activity in Prenatally Stressed Male and Female RatsCellular and Molecular Neurobiology 2022; 42(7): 2257 doi: 10.1007/s10571-021-01100-8
2
Taliha H. Aydın, Özgür D. Can, Ümide Demir Özkay, Nazlı Turan. Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanismsFundamental & Clinical Pharmacology 2016; 30(6): 549 doi: 10.1111/fcp.12224
3
Ricássio S. Barberino, Vanúzia G. Menezes, Anita E. A. S. Ribeiro, Raimundo C. Palheta Jr, Xuejun Jiang, Johan E. J. Smitz, Maria Helena T. Matos. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity†Biology of Reproduction 2017; 96(6): 1244 doi: 10.1093/biolre/iox053
4
Zhuo-Ying Tao, Richard J. Traub, Dong-Yuan Cao. Epigenetics of Chronic Pain2019; : 141 doi: 10.1016/B978-0-12-814070-3.00008-9
5
Anthony C. Johnson, Beverley Greenwood-Van Meerveld. Gastrointestinal PharmacologyHandbook of Experimental Pharmacology 2017; 239: 289 doi: 10.1007/164_2016_120
6
M Salaga, P R Polepally, M Zielinska, M Marynowski, A Fabisiak, N Murawska, K Sobczak, M Sacharczuk, J C Do Rego, B L Roth, J K Zjawiony, J Fichna. Salvinorin A analogues PR‐37 and PR‐38 attenuate compound 48/80‐induced itch responses in miceBritish Journal of Pharmacology 2015; 172(17): 4331 doi: 10.1111/bph.13212
7
Merve Kasap, Özgür Devrim Can. Opioid system mediated anti-nociceptive effect of agomelatine in miceLife Sciences 2016; 163: 55 doi: 10.1016/j.lfs.2016.08.031
8
Atousa Moghadam Fard, Pardis Goodarzi, Mehran Mottahedi, Setareh Garousi, Hamed Zadabhari, Mohammad Kalantari Shahijan, Saeedeh Esmaeili, Mohsen Nabi-Afjadi, Bahman Yousefi. Therapeutic applications of melatonin in disorders related to the gastrointestinal tract and control of appetiteNaunyn-Schmiedeberg's Archives of Pharmacology 2024;  doi: 10.1007/s00210-024-02972-5
9
Michael T. Li, Christopher Louis Robinson, Qing Zhao Ruan, Sindhuja Surapaneni, Warren Southerland. The Influence of Sleep Disturbance on Chronic PainCurrent Pain and Headache Reports 2022; 26(10): 795 doi: 10.1007/s11916-022-01074-2
10
Anita Eugenia Alencar Santos Ribeiro, Eliane Feitosa Ferreira, Jaknea dos Santos Leal, Ricássio de Sousa Barberino, Helinando Pequeno de Oliveira, Raimundo Campos Palheta Junior. Involvement of MT2 receptors in protective effects of melatonin against cisplatin-induced gastrointestinal damage in miceBrazilian Journal of Pharmaceutical Sciences 2022; 58 doi: 10.1590/s2175-97902022e20476
11
Beverley Greenwood-Van Meerveld, Dawn K. Prusator, Anthony C. Johnson. Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challengesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(11): G885 doi: 10.1152/ajpgi.00463.2014
12
Jun Zhou, Jin Zhang, XiaoHong Luo, MaoXing Li, Ying Yue, Moshe Laudon, ZhengPing Jia, RuXue Zhang. Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in ratsEuropean Journal of Pharmacology 2017; 812: 225 doi: 10.1016/j.ejphar.2017.07.001
13
Richard J. Bodnar. Endogenous opiates and behavior: 2014Peptides 2016; 75: 18 doi: 10.1016/j.peptides.2015.10.009
14
Paula Mosińska, Katarzyna Socała, Dorota Nieoczym, Moshe Laudon, Martin Storr, Jakub Fichna, Piotr Wlaź. Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in miceBehavioural Brain Research 2016; 307: 199 doi: 10.1016/j.bbr.2016.03.036